1. Antonarakis, S.E., Waber, P.G., Kittur, S.D., Patel, A.S., Kazazian, H.H., Jr., Mellis, M.A., Counts, R.B., Stamatoyannopoulos, G., Bowie, E.J.W., Fass, D.N., Pittman, D.D., Wozney, J.M., and Toole, J.J. 1985. Hemophilia A: Detection of molecular defects and of carriers by DNA analysis.New Engl. J. Med.
313: 842–848.
2. Barker, D., Schafer, M., and White, R. 1984. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.Cell
36: 131–138.
3. Bernardi, F., Bertagnolo, V., Bartolai, S., Rossi, L., Panicucci, F., and Conconi, F. 1987. A point mutation and a gene deletion of factor VIII gene in severe haemophilia A.Thromb. Haemostas.
58: 345 (Abst.).
4. Camerino, G., Bardoni, B., Sampietro, M., Romano, M., Crapanzano, C., and Mannucci, D.M. 1986. Deletion of part of coagulation factor VIII in a hemophiliac with inhibitor.Ric. Clin. Lab.
16: 227 (Abst.).
5. Cooper, D.N. and Youssoufian, H. 1988. The CpG dinucleotide and human genetic disease.Hum. Genet.
78: 151–155.